• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Human psychopharmacology: clinical and experimental >Medicines and the drug control treaties: is buprenorphine for opioid addiction at risk of being lost?
【24h】

Medicines and the drug control treaties: is buprenorphine for opioid addiction at risk of being lost?

机译：药物和药物控制条约:丁丙诺啡阿片成瘾的风险迷路吗?

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Over the past century, a worldwide system for the control of drugs with abuse potential has developed through the adoption of a series of international treaties. The important multilateral conventions currently in force are the United Nations Single Convention on Narcotic Drugs, 1961 (Single Convention), the United Nations Convention on Psychotropic Substances, 1971 (Psychotropic Convention) and the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988. From the beginning, the aim of these drug control treaties has been to control the abuse and trafficking of substances with abuse potential while assuring that the availability of these drugs for medical and scientific purposes is not unduly restricted.There is activity in the World Health Organization and the International Narcotics Control Board to determine whether the international control of buprenorphine, a partial mu-opioid agonist used as an analgesic and for the treatment of opioid addiction, should be changed from the Psychotropic Convention to the Single Convention. This change would result in the classification and regulation of buprenorphine as a narcotic drug rather than a psychotropic substance. Such a move is unwarranted medically and scientifically and would provoke increased controls on buprenorphine that would fundamentally disrupt the medical practice of pain management and opioid replacement therapy around the world. The negative impact of inappropriate regulatory controls when licensed medicines come under such scrutiny are described.
机译：在过去的一个世纪里,全球系统控制药物滥用潜力通过采用一系列的开发国际条约。多边公约目前生效联合国公约麻醉剂药物,1961(单公约),美国国家公约精神药品,1971公约(精神)和美国国家对非法交通公约麻醉药品和精神药品,1988。从一开始,这些药物控制的目的条约已经控制滥用和贩卖的物质滥用潜力同时保证这些的可用性药物用于医学和科学不是不适当的限制。卫生组织和国际麻醉品管制局确定国际控制丁丙诺啡,部分mu-opioid受体激动剂用作止痛剂和阿片类药物成瘾的治疗,应该改变从精神公约单一的公约。的分类和监管丁丙诺啡麻醉药物,而不是一个精神的物质。毫无根据的医学和科学将会引发增加控制丁丙诺啡吗这将从根本上破坏医疗实践的疼痛管理和阿片类药物世界各地的替代疗法。不适当的监管产生负面影响当授权药品受到这样的控件审查。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号